Clinical Trial Update: Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hydroxyurea in the emergency department to reduce pain during sickle cell crisis. The status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti | Conditions: Anemia, Sickle Cell, Anemia; Sickle-Cell, With Crisis | Phase 2 | Status: UNKNOWN